MARTELL RON 4
4 · Jasper Therapeutics, Inc. · Filed Feb 20, 2024
Insider Transaction Report
Form 4
MARTELL RON
DirectorPresident, CEO and Director
Transactions
- Award
Stock Option (right to buy)
2024-02-15+100,000→ 100,000 totalExercise: $17.95Exp: 2034-02-15→ Voting Common Stock (100,000 underlying)
Footnotes (1)
- [F1]1/4th of the shares subject to the option shall vest on February 15, 2025, and 1/48th of the shares subject to the option shall vest following each one-month period thereafter, subject to the Reporting Person's continuous service to the Issuer on and through each applicable vesting date, inclusive.